# Trans1

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trans1

- Industry: Medical Devices & Equipment
- Headquarters: Raleigh, US
- Website: www.trans1.com
- Total disclosed funding: $38M
- Latest round: Series C (Sep 20, 2005)
- Investors on record: 5

## About

Trans1 Inc. is a medical device company that innovates surgical solutions to enhance outcomes in spinal procedures, focusing on safety and efficiency in surgical techniques.Trans1 Inc. specializes in creating innovative medical devices for spinal surgery. The company was established in Raleigh, US, and has undergone a successful IPO in October 2007, raising USD 82.5 mn by selling 5.5 million shares at USD 15.00 each. The founder's history is not specified, and the company does not have known subsidiaries or parent companies.Trans1 specializes in advanced medical devices designed to improve surgical outcomes for spinal procedures. Its key products include the AxialLIF+ System, which provides safe access to the L5-S1 vertebral bodies for interbody fusion, and the Vectre™ Facet Fusion System, which utilizes a cannulated facet screw mechanism for safe posterior fixation. These products cater to the needs of spinal surgeons and healthcare facilities aiming to enhance surgical efficacy and patient outcomes in various international markets.Trans1 generates revenue primarily through the sales of its specialized medical devices, with total revenue in the most recent year recorded at USD 14.57 mn. The company’s transactions typically occur on a B2B basis, involving direct dealings with hospitals and surgical centers for its core products, focusing on one-time purchases or ongoing supply contracts.Following its IPO in October 2007, Trans1 plans to utilize the raised funds to support the development of new products and to expand its market presence. They are working on upcoming enhancements to their existing product lines, while also targeting entry into new geographic regions to increase their market reach. Specific timelines for these initiatives were not provided.

## Funding rounds

- Series C, Sep 20, 2005, $26M — Advanced Technology Ventures, Delphi Ventures, Sapient Capital, Kearny Venture Partners, Cutlass Capital
- Series B, May 6, 2003, $12M — Advanced Technology Ventures, Delphi Ventures, Sapient Capital, Cutlass Capital

## Investors

- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series B, Series C
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series B, Series C
- Sapient Capital (https://capitalatlas.ai/funds/sapient-capital) — Series B, Series C
- Cutlass Capital (https://capitalatlas.ai/funds/cutlass-capital) — Series B, Series C
- Kearny Venture Partners (https://capitalatlas.ai/funds/kearny-venture-partners) — Series C